PBM Lobby: FDA's Nonprescription Drug Push Could Disrupt Supply Chain, Hike Consumer Costs

October 09, 2018
The pharmacy benefit manager lobby tells FDA to tread carefully in its push to increase the availability of nonprescription drugs through use of mobile apps and other technology, warning the move could inadvertently disrupt the pharmaceutical supply chain and actually increase out-of-pocket costs for some consumers. FDA's plan for patients to use new technologies to self-select over-the-counter (OTC) drugs would leave those that don't have cell phones or are illiterate without needed medications, the Pharmaceutical Care Management Association says. The...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.